propidium has been researched along with 3,3',4,5'-tetrahydroxystilbene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhaus, A; Fritzer-Szekeres, M; Graser, G; Grusch, M; Horvath, Z; Jaeger, W; Ozsvar-Kozma, M; Pemberger, M; Saiko, P; Savinc, I; Szekeres, T | 1 |
| Kim, Y; Schmeel, FC; Schmeel, LC; Schmidt-Wolf, IG | 1 |
2 other study(ies) available for propidium and 3,3',4,5'-tetrahydroxystilbene
| Article | Year |
|---|---|
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Models, Chemical; Propidium; Ribonucleotide Reductases; Stilbenes; Time Factors | 2008 |
Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fibroblasts; Humans; Immunotherapy; Inhibitory Concentration 50; Mice; Multiple Myeloma; Propidium; Stilbenes; Treatment Outcome; Wnt Proteins; Wnt Signaling Pathway | 2014 |